Management Team

William T. Sharp

Co-founder, Chief Executive Officer & Director

With more than thirty years of executive, general management, business development, sales, marketing, and technology commercialization experience, Mr. Sharp’s career spans private venture-backed businesses, mid-size, and Fortune 100 public companies in the medical device, diagnostics, and life science tools and services markets. Mr. Sharp has served in senior leadership roles with five venture-backed companies – as Chief Executive Officer of CYTOO, Inc. and ArunA Biomedical, Chief Commercial Officer of BioProcessors Corporation (acquired by Seahorse Biosciences), SVP Business Development of Cellomics (acquired by Fisher International), and VP Business Development of Gentra Systems (acquired by Qiagen). Earlier career includes senior leadership roles with Life Technologies, General Manager of Terumo Medical, Vice President of Sales and Marketing at Heraeus Instruments and roles of increasing responsibility within the diagnostics business of Baxter Healthcare and a medical device subsidiary of Eli Lilly. Mr. Sharp has successfully commercialized more than 500 products and services. Earned M.S. and B.A. degrees from the Pennsylvania State University.  www.linkedin.com/in/billsharp1

 

Kevin Sly

Chief Operating Officer

Bringing over 25 years of experience in the pharmaceutical, biomedical and biotechnology industries to DxNow, Mr. Sly has global responsibility for marketing, regulatory, manufacturing and overall business operations. Prior to joining the DxNow team, Mr. Sly directed the commercial strategy, marketing and business development activities for Baltimore-based Paragon Bioservices. Throughout his career, Mr. Sly’s focus has primarily been strategic marketing and business development, from leading the efforts in pharmaceutical technology licensing and product development (including Phase I–III development and commercial manufacturing), to the development of business strategy and strategic commercial development for a range of biopharmaceutical products. Mr. Sly joined the Maryland business community in 2002 as Chief Business Officer for a private start-up, Advancis Pharmaceutical Corporation, playing a critical role in establishing a strong marketing presence, delivering key validating licensing and acquisition deals, serving on the core IPO deal team and leading the post-IPO efforts to establish the company’s first commercial operations. He received his BA in Biology (pre-med) from Pomona College.  www.linkedin.com/in/kevinsly

 

Brad Burrows

Chief Commercial Officer

Mr. Burrows brings more than 25 years of commercial experience in the healthcare industry with a proven track record in sales management, training and development, corporate accounts, and business development. His sales and management background includes medical devices, diagnostic products, imaging, point-of-care, research, and life sciences. Prior to DxNow, Mr. Burrows served in various commercial and sales leadership positions with several large healthcare companies, including Thermo Fisher Scientific, Alere Inc., Biosite, Maquet (formerly Datascope), and Abbott Laboratories. As Chief Commercial Officer, his primary focus will be in leading DxNow’s global direct sales initiatives through increased brand awareness and product commercialization in the fertility marketplace.  linkedin.com/in/brad-burrows-316bba175

 

Jay Rau

Vice President, Business Development

Mr. Rau’s career extends over three decades in sales, sales management, business development, basic research and product development. His responsibilities for DxNow are currently focused on developing our global business efforts in veterinary fertility and our human fertility distribution network in the Asia-Pacific region. Mr. Rau’s experience spans venture-backed businesses, mid-size, and Fortune 500 public companies in the medical device, diagnostics, and life science tools and services markets. Mr. Rau’s venture-backed experience includes his most recent role as Director of Business Development for Spartan Bioscience in which he successfully established global distribution channels plus engaged in the initiation and direction of collaborative partnerships. Previous business development, sales, and sales management experience includes fourteen years with Gentra Systems (acquired by Qiagen) where he held all sales records, Sequenom, and Pall Corporation. During his early career, Mr. Rau gained basic research and product development experience at Kallestad (now owned by Danaher – Beckman Coulter), the University of Wisconsin and the University of Minnesota. Mr. Rau earned his B.S. degree from the University of Wisconsin-Madison.  www.linkedin.com/in/jay-rau-9593476

 

Bob Gallahue

Advisor, Finance

Mr. Gallahue has over 20 years of financial management experience in public and private biotechnology and medical technology companies in the various facets of start‐up through public company environments, including three IPOs, three mergers, joint ventures, private financings and follow‐on offerings. Mr. Gallahue has served as CFO of CorNova, Inc., Cibiem Inc., Molecular Insight, and Keryx Biopharmaceuticals and has worked in high level financial positions at Millennium Pharmaceuticals and LeukoSite Inc. He started his career at PricewaterhouseCoopers, LLP where he was a C.P.A. responsible for auditing. Mr. Gallahue holds a M.S.A. from Bentley College and B.A. from Middlebury College.  www.linkedin.com/in/bob-gallahue-7a5aaa7